secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gain Therapeutics, Inc. (GANX)
CIK:        0001819411
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001104659-24-074822
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Gain Therapeutics stockholders elect eight directors, ratify Ernst & Young as auditor at annual meeting
--------------------------------------------------------------------------------

- All eight director nominees elected; broker non-votes of 5,183,098 shares on each nominee.
- Vote totals for directors ranged from 4,308,578 (Hasler) to 6,581,651 (Richman).
- Ernst & Young AG ratified as independent auditor for FY2024: 11,836,784 for, 119,833 against, 35,623 abstain.
- Meeting held June 24, 2024 with quorum present.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819411/000110465924074822/0001104659-24-074822-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819411/000110465924074822/tm2418205d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-074822

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer